Glaukos Submits FDA New Drug Application for IDose TR
By Robb M. Stewart
Glaukos Corp. said Monday it has submitted a new drug application to U.S. regulators for iDose TR, a micro-invasive intraocular implant designed to continuously deliver therapeutic levels of a…